ArticleInvestigational new drugs2025
Multicenter retrospective study of selpercatinib treatment for advanced or recurrent RET fusion-positive non-small cell lung cancer in Japan.
Yasuhiro Mihashi et al.PubMed ↗Publisher ↗
No numbers read from the abstract.